uMotif

Engaged Patients.
Better Trials.

The most modern eConsent and eCOA/ePRO platform powering clinical and real-world research.

Book a demo

We empower the trusted relationship between patient and site for increased recruitment, higher compliance, and fewer dropouts.

The uMotif Advantage

We Start with the Patient.

Patient centricity is the bedrock of modern eCOA systems and the key to delivering a superior participant experience and exceptional data capture. 

Since 2012, uMotif’s eCOA platform has been setting a new standard for patient-centric studies — providing a better experience for participants, sites, and sponsors — to drive high compliance and engagement, reduce dropouts, and improve study retention and data completeness.

Smiling woman on a teal chair uses her phone; beside her, two smartphone mockups show a research study app with daily tasks and mood questionnaire—Morning/Evening Diary, EQ-5D-5L, and About/Do’s & Don’ts sections.
Row of tablets and phones showing a healthcare study app—site map, a tablet “Site Report” dashboard with charts and tables, symptom diary screen, EQ-5D-5L health rating slider, and a tele-visit video call.

Modern All-in-One eCOA Platform.

uMotif’s cloud native solutions are designed for configurability and scalability to quickly adapt to protocol-specific requirements and provide optimal flexibility for sponsors, sites, and patients. 

Our customers are never burdened with legacy technology that does not support modern patient interfaces or lacks tool sets that enable faster and higher quality deployments.

Tools to Bolster the Patient-Site Relationship.

uMotif solutions — including eConsent/Consent Management, Trial Awareness, Patient Ride with Uber Health, and Site Productivity — strengthen the patient-site relationship, which is key to improving eCOA compliance and retention. 

Collage of healthcare study tech and real-world use: a nurse helps an older woman with a phone, a caregiver assists a woman into a car, and nearby device screens show a study app home, a tele-visit video call, and a tablet dashboard with charts.
Four infographic badges on a black background: “35+ TA” with a yellow app-grid icon; “130+ Studies” with a teal document and magnifying glass; “35 Languages” with pink speech bubbles; and “Phases I–IV” with a blue bar chart and people.

Global. Scalable. Proven.

With cloud-hosting in the US, Europe, and China, the GCP, 21 CFR Part 11 and GDPR-compliant platform supports all study phases and indications.

Real Partnership. Ready to Adapt.

With uMotif, you can expect high-touch support from kickoff to closeout. We work to earn your trust, demonstrate expertise, and communicate with transparency, ensuring that your study is completed on scope, on time, and with the highest quality. We also know that things change, and we’re ready to adapt to your needs. 

The uMotif team is led by industry innovators with decades of experience in clinical trials, site operations, technology, and patient engagement. We know what it takes to execute globally and at scale. 

Overlapping circular collage: a hand holds a smartphone showing the uMotif petal diary, behind are meeting and seminar scenes, and on the right a clinician speaks with colleagues; uMotif logo centered.

In the News

  • 2025 SCRS Global Site Solutions Summit: How Sites Can Overcome Technology Burdens in Clinical Trials

    Read More

  • uMotif Recognized as a Major Contender in Everest Group’s Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment 2025

    Read More

  • uMotif to Showcase Modern eConsent and eCOA Platform to Support the Pivotal Patient-Site Relationship in Clinical Trials at Fall 2025 Life Sciences Conferences

    Read More